Clinical Trials Logo

Vascular Disease, Peripheral clinical trials

View clinical trials related to Vascular Disease, Peripheral.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05710653 Completed - Clinical trials for Endothelial Dysfunction

Inter-individual Physiological Response to a Training and Detraining Period in Cardiometabolic Risk Factors Subjects

VASCU-HEALTH
Start date: June 28, 2022
Phase: N/A
Study type: Interventional

Background: Although exercise training is a well described therapy for some cardiometabolic diseases such as obesity, type 2 diabetes, arterial hypertension, and metabolic syndrome, there is scarcity of knowledge about the post-exercise period term as 'detraining' where usually all physiological adaptations as cardiovascular and metabolic benefits are lost due to physical inactivity. Likewise, as some exercise training modalities as high-intensity interval training improve vascular parameters including endothelial dysfunction parameters as flow-mediated dilation (FMD%), and carotid-intima media thickness (c-IMT) during the 'training' period, there is little knowledge about how many 'volume' or 'intensity' of exercise training or physical activity per week is needed to maintain the exercise training benefits in populations with cardiometabolic risk factors such as those patients with arterial hypertension. This information will be of great interest for both improving and maintaining the vascular profile and health of Chilean adults with risk factors and to maintain a better vascular profile. Objective: To study the beneficial adaptations from the 'training' and 'detraining' period of exercise training on functional and structural vascular parameters in healthy and cardiometabolic risk factors adult subjects to improve the health profile. Methods: The investigators will conduct an experimental design of 5 groups of exercise training in healthy (controls) and hypertensive (HTN) patients (≥140 mmHg), with overweight/or obesity, men and women, with BMI ≥25 and ≤35 kg/m2, aged ≥18y, physically inactive (<150 min/week of low/moderate PA/week, or <75 min/week of vigorous PA) in the last 6 months will be invited for participating. The groups will be as follows; Group (HTNex will be compared with Group HTNcg). Group (ELEex will be compared with Group ELEcg). Group (NTex will be compared with Group NTcg). Each group will be compared in their physiological vascular adaptations before and after exercise training such as HIIT, and after 3 months of a detraining period. Results (hypothesis): The investigators hypothesized that the maintenance of vascular outcomes after the 'detraining' period is intensity-dependent in adults with HTN that participated of an exercise intervention.

NCT ID: NCT04585763 Completed - Clinical trials for Peripheral Arterial Disease

Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System

Disrupt PAD+
Start date: February 16, 2021
Phase: N/A
Study type: Interventional

Prospective, multi-center, single-arm study of the M5+ Peripheral IVL system to treat calcified peripheral arteries.

NCT ID: NCT04146493 Completed - Clinical trials for Cardiovascular Diseases

Heparin-Binding Protein and Heparins

HepHep
Start date: April 1, 2019
Phase:
Study type: Observational

Heparin-Binding protein is a protein from primary and secretory granluae of white blood cells. It is released when white blood cells become activated and has been advocated as a biomarker for sepsis. The aim of this study is to find out if Heparins in clinical doses can change the level of Heparin-binding protein in plasma.

NCT ID: NCT02135848 Completed - Clinical trials for Vascular Disease, Peripheral

3 Month PHI PAD PoM Study

Start date: October 15, 2010
Phase: Phase 2
Study type: Interventional

This is a multi-center, randomized, blinded, placebo controlled study to evaluate the safety of GSK1278863 and its acute and short-term (e.g. 14d) effects on calf muscle endurance and walking ability in subjects with PAD and symptomatic claudication.